2158 Federal Register / Vol. 83, No. 10 / Tuesday, January 16, 2018 / Notices 

manufacturers have in place the capital 

equipment necessary to comply with the 

Rule’s labeling requirements. Based on 

knowledge of the industry, staff believes 

that much of the information required 

by the Rule would be included on the 

product label even absent those 

requirements. 

Request for Comments 

You can file a comment online or on 

paper. March 19, 2018. Write ‘‘Care 

Labeling Rule: FTC File No. P072108’’ 

on your comment. Your comment— 

including your name and your state— 

will be placed on the public record of 

this proceeding, including, to the extent 

practicable, on the public Commission 

website, at https://www.ftc.gov/policy/ 

public-comments. Postal mail addressed 

to the Commission is subject to delay 

due to heightened security screening. As 

a result, we encourage you to submit 

your comments online. To make sure 

that the Commission considers your 

online comment, you must file it at 

https://ftcpublic.commentworks.com/ 

ftc/carelabelingrulepra1 by following 

the instructions on the web based form. 

If this Notice appears at https://

www.regulations.gov, you also may file 

a comment through that website. 

If you file your comment on paper, 

write ‘‘Care Labeling Rule: FTC File No. 

P072108’’ on your comment and on the 

envelope, and mail your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW, Suite 

CC–5610 (Annex C), Washington, DC 

20580, or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW, 

5th Floor, Suite 5610, Washington, DC 

20024. If possible, submit your paper 

comment to the Commission by courier 

or overnight service. 

Because your comment will be placed 

on the publicly accessible FTC website 

at www.ftc.gov, you are solely 

responsible for making sure that your 

comment does not include any sensitive 

or confidential information. In 

particular, your comment should not 

include any sensitive personal 

information, such as your or anyone 

else’s Social Security number; date of 

birth; driver’s license number or other 

state identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure that your 

comment does not include any sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . is privileged or 

confidential’’—as provided by Section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including in particular competitively 

sensitive information such as costs, 

sales statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Comments containing material for 

which confidential treatment is 

requested must be filed in paper form, 

must be clearly labeled ‘‘Confidential,’’ 

and must comply with FTC Rule 4.9(c). 

In particular, the written request for 

confidential treatment that accompanies 

the comment must include the factual 

and legal basis for the request, and must 

identify the specific portions of the 

comment to be withheld from the public 

record. See FTC Rule 4.9(c). Your 

comment will be kept confidential only 

if the General Counsel grants your 

request in accordance with the law and 

the public interest. Once your comment 

has been posted on the public FTC 

website—as legally required by FTC 

Rule 4.9(b)—we cannot redact or 

remove your comment from the FTC 

website, unless you submit a 

confidentiality request that meets the 

requirements for such treatment under 

FTC Rule 4.9(c), and the General 

Counsel grants that request. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before March 19, 2018. You can find 

more information, including routine 

uses permitted by the Privacy Act, in 

the Commission’s privacy policy, at 

https://www.ftc.gov/site-information/ 

privacy-policy. 

David C. Shonka, 

Acting General Counsel. 

[FR Doc. 2018–00538 Filed 1–12–18; 8:45 am] 

BILLING CODE 6750–01–P 

GOVERNMENT ACCOUNTABILITY 

OFFICE 

Request for Medicaid and CHIP 

Payment and Access Commission 

Nominations 

AGENCY: U.S. Government 

Accountability Office (GAO). 

ACTION: Request for letters of 

nomination and resumes. 

SUMMARY: The Children’s Health 

Insurance Program Reauthorization Act 

of 2009 (CHIPRA) established the 

Medicaid and CHIP Payment and 

Access Commission (MACPAC) to 

review Medicaid and CHIP access and 

payment policies and to advise Congress 

on issues affecting Medicaid and CHIP. 

CHIPRA gave the Comptroller General 

of the United States responsibility for 

appointing MACPAC’s members. GAO 

is now accepting nominations for 

MACPAC appointments that will be 

effective May 1, 2018. Letters of 

nomination and resumes should be 

submitted no later than February 5, 

2018 to ensure adequate opportunity for 

review and consideration of nominees 

prior to the appointment of new 

members. Nominations should be sent 

to the email or mailing address listed 

below. Acknowledgement of 

submissions will be provided within a 

week of submission. Please contact Will 

Black at (202) 512–6482 if you do not 

receive an acknowledgement. 

ADDRESSES: 

Email: MACPACappointments@

gao.gov. 

Mail: U.S. GAO, Attn: MACPAC 

Appointments, 441 G Street NW, 

Washington, DC 20548. 

FOR FURTHER INFORMATION CONTACT: 

GAO: Will Black, (202) 512–6482, 

BlackW@gao.gov, Office of Public 

Affairs, (202) 512–4800. 

Public Law 111–3, Section 506; 42 

U.S.C. 1396. 

Gene L. Dodaro, 

Comptroller General of the United States. 

[FR Doc. 2018–00117 Filed 1–12–18; 8:45 am] 

BILLING CODE 1610–02–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Public Health Preparedness and 

Response, (BSC, OPHPR) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Board of Scientific Counselors, 

Office of Public Health Preparedness 

and Response, (BSC, OPHPR). This 

meeting is open to the public. The 

public is welcome to listen to the 

meeting via Adobe Connect. Preregistration is required by clicking the 

links below. WEB ID: (100 seats) https:// 


daltland on DSKBBV9HB2PROD with NOTICES